Search





Search





Markets
/
Stocks
/
nmra
/

Neumora Therapeutics Inc

NMRA

Add to Watchlist

1.610USD

-0.040-2.42%

Close 07-31 16:00（ET）Quotes delayed by 15 min

298.31MMarket Cap

LossP/E TTM

Neumora Therapeutics Inc

1.610

-0.040-2.42%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

NMRA Cash Flow Statement

You can access the annual and quarterly cash flow statements of Neumora Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

21.94%-46.40M

4.74%-47.95M

-39.27%-46.63M

6.68%-52.40M

-38.40%-59.45M

2.14%-50.34M

29.91%-33.48M

-81.03%-56.16M

-30.01%-42.95M

---51.44M

---47.77M

-16.71%-31.02M

-2.66%-33.04M

-95.92%-26.58M

-111.14%-32.19M

-77.76%-29.35M

---17.26M

---13.57M

---15.24M

---16.51M

Net income from continuing operations

21.38%-53.46M

-1.07%-59.45M

21.77%-56.76M

10.17%-52.73M

-26.57%-67.99M

45.90%-58.82M

-36.81%-72.55M

-52.30%-58.70M

-50.80%-53.72M

---108.73M

---53.03M

-26.90%-38.54M

17.23%-35.63M

-78.54%-30.37M

-181.25%-43.04M

-34.86%-26.97M

---178.03M

---17.01M

---15.30M

---20.00M

Operating gains losses

-94.90%8.00K

43.95%226.00K

-85.26%23.00K

148.13%397.00K

-0.63%157.00K

-5.42%157.00K

-9.83%156.00K

-6.43%160.00K

0.00%158.00K

--166.00K

--173.00K

11.04%171.00K

7.48%158.00K

23.20%154.00K

11.36%147.00K

-68.28%131.00K

--150.00K

--125.00K

--132.00K

--413.00K

Other non-cash items

215.78%477.00K

369.33%606.00K

36.02%-302.00K

122.69%307.00K

-15.73%-412.00K

-100.35%-225.00K

-166.67%-472.00K

-366.55%-1.35M

-356.41%-356.00K

--64.18M

---177.00K

-199.66%-290.00K

-100.59%-78.00K

7.38%291.00K

8163.75%13.22M

-82.72%803.00K

--156.86M

--271.00K

--160.00K

--4.65M

Change in working capital

-45.71%-765.00K

336.65%3.21M

-84.77%4.48M

15.82%-7.60M

-114.62%-525.00K

89.66%-1.36M

2567.23%29.43M

-277.22%-9.03M

1062.14%3.59M

---13.11M

---1.19M

194.62%5.10M

107.62%309.00K

-20.97%1.73M

-338.96%-4.06M

-97.44%-4.48M

--2.25M

--2.19M

---924.00K

---2.27M

-Change in prepaid expenses

70.19%1.64M

-693.49%-3.56M

-101.84%-326.00K

101.49%145.00K

-86.86%966.00K

107.37%599.00K

356.79%17.69M

-129.56%-9.74M

-6.45%7.35M

---8.13M

---6.89M

-3219.12%-4.24M

1121.85%7.86M

-24.02%136.00K

-251.08%-769.00K

-2451.69%-2.27M

---677.00K

--179.00K

--509.00K

---89.00K

-Change in other current assets

----

--0.00

--1.00K

---54.00K

----

--0.00

-100.00%0.00

100.00%0.00

51046.67%7.67M

-10758.82%-3.62M

--5.00K

---59.00K

--15.00K

--34.00K

Cash from non-recurring investing activities

Cash from operating activities

21.94%-46.40M

4.74%-47.95M

-39.27%-46.63M

6.68%-52.40M

-38.40%-59.45M

2.14%-50.34M

29.91%-33.48M

-81.03%-56.16M

-30.01%-42.95M

---51.44M

---47.77M

-16.71%-31.02M

-2.66%-33.04M

-95.92%-26.58M

-111.14%-32.19M

-77.76%-29.35M

---17.26M

---13.57M

---15.24M

---16.51M

Investing cash flow

Net cash from continuing investing activities

---71.00K

-100.03%-63.00K

99.95%-71.00K

99.79%-84.00K

100.00%0.00

4956.99%234.34M

-424391.89%-156.99M

-192.00%-40.79M

19.18%-35.80M

--4.63M

--37.00K

24260.44%44.34M

-436.22%-44.30M

66.97%182.00K

48900.00%13.18M

-39.35%188.00K

--547.00K

--109.00K

---27.00K

--310.00K

Capital expenditures

----

-100.00%0.00

--16.00K

--0.00

-100.00%0.00

4956.99%234.34M

-100.00%0.00

2052.78%775.00K

--4.63M

--37.00K

24260.44%44.34M

-99.73%36.00K

30.94%182.00K

4726.37%13.18M

-85.54%188.00K

--547.00K

--139.00K

--273.00K

--1.30M

Net cash flow from disposal of fixed assets

---71.00K

-100.03%-63.00K

99.95%-71.00K

99.79%-84.00K

----

4956.99%234.34M

-424391.89%-156.99M

-192.00%-40.79M

17.43%-36.58M

--4.63M

--37.00K

24260.44%44.34M

-436.22%-44.30M

66.97%182.00K

48900.00%13.18M

-39.35%188.00K

--547.00K

--109.00K

---27.00K

--310.00K

Net cash flow from intangible asset transactions

----

--0.00

-100.00%0.00

--0.00

--775.00K

----

Net cash flow from investment products

-100.00%0.00

-68.58%42.58M

--51.25M

255.16%30.31M

123.77%44.16M

640.22%135.54M

----

-128.56%-19.54M

-347.90%-185.80M

--18.31M

--23.85M

175.27%68.41M

42.73%-41.48M

---90.89M

---72.43M

--0.00

Net cash flow from other investing activities

--0.00

-99.80%16.00K

---16.00K

----

--8.10M

----

Cash from non-current investing activities

Net cash flow from investing activities

-99.84%71.00K

143.16%42.65M

-67.31%51.32M

43.01%30.40M

129.44%44.16M

-822.37%-98.80M

559.20%156.99M

-11.72%21.25M

-5424.85%-150.00M

--13.68M

--23.82M

126.44%24.08M

103.29%2.82M

-83450.46%-91.07M

-317159.26%-85.61M

39.35%-188.00K

---547.00K

---109.00K

--27.00K

---310.00K

Financing cash flow

Cash flow from continuous financing activities

--10.88M

277.37%58.77M

-108.88%-136.00K

595.44%18.46M

-100.00%0.00

3337.63%15.57M

-99.34%1.53M

808.90%2.65M

1726.73%1.84M

---481.00K

--232.02M

-85.98%292.00K

128.77%101.00K

225.47%2.08M

-128.31%-351.00K

-103.03%-358.00K

--291.99M

--640.00K

--1.24M

--11.80M

Net cash flow from debt Issuance/repayment

----

--38.90M

---136.00K

--18.40M

----

Net cash flow from common stock issuance/repurchase

--10.88M

43.52%19.65M

----

--13.69M

----

--0.00

100.00%0.00

--0.00

--233.38M

--0.00

---491.00K

--0.00

-100.00%0.00

--0.00

--960.00K

--0.00

Net cash flow from preferred stock issuance/repurchase

----

-100.53%-63.00K

--291.24M

----

--11.80M

Proceeds from stock option exercised by employees

----

-86.94%216.00K

-100.00%0.00

-97.78%59.00K

-100.00%0.00

387.91%1.65M

16.21%1.76M

556.93%2.65M

206.48%1.84M

--339.00K

--1.51M

-82.50%404.00K

267.07%602.00K

260.63%2.31M

-41.43%164.00K

--846.00K

--743.00K

--640.00K

--280.00K

--0.00

Net cash flow from other financing activities

--0.00

8634.67%19.65M

39.56%-136.00K

----

127.44%225.00K

92.14%-225.00K

100.00%0.00

---820.00K

---2.86M

50.22%-112.00K

98.06%-10.00K

---225.00K

---515.00K

---1.14M

----

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--10.88M

277.37%58.77M

-108.88%-136.00K

595.44%18.46M

-100.00%0.00

3337.63%15.57M

-99.34%1.53M

808.90%2.65M

1726.73%1.84M

---481.00K

--232.02M

-85.98%292.00K

128.77%101.00K

225.47%2.08M

-128.31%-351.00K

-103.03%-358.00K

--291.99M

--640.00K

--1.24M

--11.80M

Net cash flow

Beginning cash balance

27.32%182.53M

-53.39%129.07M

-18.02%124.52M

-30.45%128.07M

-61.80%143.36M

-33.03%276.93M

-26.06%151.89M

-13.18%184.14M

54.93%375.25M

--413.50M

--205.43M

-27.18%212.08M

-40.83%242.21M

63.50%291.23M

113.10%409.37M

122.84%439.27M

--165.09M

--178.13M

--192.10M

--197.12M

Current period cash flow changes

-131.93%-35.46M

140.02%53.46M

-96.36%4.55M

88.99%-3.55M

92.00%-15.29M

-249.23%-133.57M

-39.91%125.04M

-384.80%-32.25M

-534.44%-191.11M

---38.25M

--208.07M

94.24%-6.65M

74.50%-30.12M

-786.52%-115.57M

-745.27%-118.14M

-495.46%-29.90M

--274.18M

---13.04M

---13.98M

---5.02M

Ending cash balance

14.83%147.07M

27.32%182.53M

-53.39%129.07M

-18.02%124.52M

-30.45%128.07M

-61.80%143.36M

-33.03%276.93M

-26.06%151.89M

-13.18%184.14M

--375.25M

--413.50M

16.95%205.43M

-27.18%212.08M

6.40%175.66M

63.50%291.23M

113.10%409.37M

--439.27M

--165.09M

--178.13M

--192.10M

Free cash flow

21.94%-46.40M

83.15%-47.95M

-39.32%-46.65M

6.68%-52.40M

-35.94%-59.45M

-407.67%-284.68M

29.97%-33.48M

25.48%-56.16M

-32.21%-43.73M

---56.08M

---47.81M

-181.59%-75.36M

27.08%-33.08M

-95.26%-26.76M

-192.34%-45.36M

-65.84%-29.54M

---17.80M

---13.71M

---15.52M

---17.81M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Neumora Therapeutics Inc Generate?



Neumora Therapeutics Inc generated -206.44M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Neumora Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Neumora Therapeutics Inc's operating cash flow increased by -12.85% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Neumora Therapeutics Inc's Financing Cash Flow Changed?



Neumora Therapeutics Inc used 77.09M in financing activities in the latest quarter.

What is free cash flow and why does it matter for NMRA?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Neumora Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -206.44M reflecting a -12.37% change from the previous year.